search

Active clinical trials for "Ulcer"

Results 161-170 of 2094

the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis

Ulcerative Colitis

This is a randomized, controlled study evaluating diosmin tablets administered daily for 3 months. The purpose of the study is to evaluate the efficacy and safety of diosmin in the treatment of mild to moderately active ulcerative colitis. Disease activity will be measured using modified truelove and witt's classification.

Recruiting13 enrollment criteria

Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently?

Peripheral Vascular DiseaseDiabetic Foot Ulcer1 more

The goal of this multicenter, multi-national, multi-arm, multi-stage, randomized controlled trial, is to determine the added benefit of hyperbaric oxygen treatment (HBOT) in patients with diabetic foot ulcers and peripheral vascular disease. The main question is: - What is the difference is the major amputation rate between the study arms? Participants will be randomized to 20, 30 or 40 sessions of HBOT or a control group.

Recruiting17 enrollment criteria

Broccoli Sprouts for Mild Ulcerative Colitis

Ulcerative ColitisUlcerative Colitis Chronic Mild

The goal of this study is to determine the number of servings of broccoli sprouts sufficient to (1) increase sulforaphane levels in the stool and blood and (2) reduce inflammatory markers in patients with mild ulcerative colitis. This is a pilot feasibility study to prepare for a larger randomized controlled trial.

Recruiting16 enrollment criteria

A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894)...

Ulcerative Colitis

This is a study to learn if the experimental medicine (called PF-07054894) is safe, effective, and how it is processed in adult people with ulcers in the colon.

Recruiting10 enrollment criteria

A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis...

ColitisUlcerative

The purpose of this study is to evaluate the efficacy, including clinical remission of guselkumab subcutaneous (SC) induction compared to placebo in participants with moderately to severely active ulcerative colitis (UC).

Recruiting10 enrollment criteria

Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic...

Diabetic FootDiabetic Foot Ulcer2 more

The study will evaluate the safety and performance of Symphony™ versus Standard of Care (SOC) in the treatment of chronic non-healing diabetic foot ulcers (DFU) after 12 weeks of treatment.

Recruiting25 enrollment criteria

The GORE® VIAFORT Vascular Stent IVC Study

Venous ThrombosesVenous Disease8 more

This study is a prospective, multicenter, non-randomized, single-arm study to evaluate the performance, safety, and efficacy of the GORE® VIAFORT Vascular Stent for treatment of symptomatic inferior vena cava obstruction with or without combined iliofemoral obstruction in adult patients.

Recruiting37 enrollment criteria

A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis

Ulcerative Colitis (UC)

To evaluate the efficacy of IBI112 induction therapy in patients with moderate and severe active Ulcerative Colitis (UC) to achieve clinical remission.

Recruiting7 enrollment criteria

Combined Electromagnetic Field and a Plantar Resistance Exercise With Venous Leg Ulcer

Venous Leg Ulcer

The purpose of this study will investigate the effects of combined electromagnetic field and a plantar resistance exercise therapy versus electromagnetic field on healing of venous leg ulcer .

Recruiting6 enrollment criteria

Topical Sevoflurane for Treatment of Chronic Leg Ulcers

Leg Ulcer

Patients with painful non-healing leg ulcer will be enrolled in the clinical single-blinded randomized study. The active treatment group will have sevoflurane applied at approximately 1 ml/cm2 at the start of wound treatment, the control group will only have a standard rinse solution with Cyteal TM (Pierre Fabre Medicament, France). Further treatment will then be carried out in the standard manner. The duration of the study will be 5 days; if the defect heals earlier, it will be terminated early. Exclusion criteria: allergy to sevoflurane, inability to understand the questionnaire Parameters to be monitored will be pain intensity, microbial colonization, appearance and size of the defect

Recruiting3 enrollment criteria
1...161718...210

Need Help? Contact our team!


We'll reach out to this number within 24 hrs